Revenue
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | £306.4M | £270.0M | £202.5M | £182.7M | — |
| Operating expenses | £70.2M | £62.6M | £55.1M | £49.6M | — |
| Operating income | £34.1M | £27.8M | £21.2M | £15.3M | — |
| Operating margin | 11.13% | 10.31% | 10.46% | 8.35% | — |
| EBITDA | £48.4M | £35.6M | £29.2M | £23.1M | — |
| EBITDA margin | 15.78% | 13.17% | 14.44% | 12.63% | — |
| Net income | £23.9M | £19.2M | £15.3M | £11.4M | — |
| Net profit margin | 7.80% | 7.13% | 7.56% | 6.22% | — |
| Basic EPSper basic share | £0.52 | £0.45 | £0.38 | £0.28 | — |
| Diluted EPSper diluted share | £0.51 | £0.44 | £0.38 | £0.28 | — |
Reported major voting-rights holders
| Holder | Voting rights |
|---|---|
Octopus Investments Limited | 5.02%Apr 2, 2026 · 2.36M votes |
Rathbones Investment Management Ltd | 5.00%Jul 24, 2026 · 2.35M votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Cohort ($CHRT) reported an order book of approximately £700 million, up from £618.8 million at the end of its previous financial year. The backlog underpins nearly 90% of the market’s revenue expectations for fiscal 2027. The defense-techno ...